San Francisco, CA, United States of America

Deepta Bhattacharya

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovator Deepta Bhattacharya: Pioneering Stem Cell Transplantation**

Introduction

Deepta Bhattacharya is an accomplished inventor based in San Francisco, CA, known for his significant contributions to the field of stem cell research. With two patents under his name, he continues to push the boundaries of medical science, specifically in enhancing stem cell transplantation techniques.

Latest Patents

One of Bhattacharya's notable patents is on the "Selective immunodepletion of endogenous stem cell niche for engraftment." This invention presents a transformative method for stem cell transplantation that enables successful engraftment while restoring the immune competence of the recipient. Crucially, this process eliminates the need for radiotherapy or chemotherapy, minimizing the risks associated with graft-versus-host disease (GVHD) or graft rejection. The underlying principle of this invention is the depletion of the endogenous stem cell niche, which facilitates the efficient integration of exogenous stem cells. By using selective ablation of endogenous stem cells alongside the administration of exogenous stem cells, this method not only ensures effective long-term engraftment but also promotes tolerance in the recipient.

Career Highlights

Bhattacharya is affiliated with Leland Stanford Junior University, where he works at the forefront of scientific research and innovation. His academic and research endeavors have positioned him as a leader in stem cell technology, and his inventions are crucial steps towards improving patient outcomes in stem cell therapies.

Collaborations

Throughout his career, Bhattacharya has collaborated with distinguished colleagues, including Irving L. Weissman and Agnieszka Czechowicz. These partnerships highlight the collaborative nature of scientific advancement, where sharing knowledge and expertise leads to groundbreaking innovations.

Conclusion

Deepta Bhattacharya's work exemplifies the spirit of innovation in the medical field. His patents not only advance the understanding of stem cell transplantation but also represent a significant leap forward in creating safer and more effective treatments for patients. As researchers like Bhattacharya continue to develop transformative techniques, the future of medicine looks promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…